Cargando…
The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?
In this perspective, we congratulate the international efforts to highlight critical challenges in brain tumor research through a recent Consensus Statement. We also illustrate the importance of developing more accurate and clinically relevant early translational in vitro brain tumor models—a perspe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468723/ https://www.ncbi.nlm.nih.gov/pubmed/30934632 http://dx.doi.org/10.3390/cancers11030426 |
_version_ | 1783411499415371776 |
---|---|
author | Rominiyi, Ola Al-Tamimi, Yahia Collis, Spencer J. |
author_facet | Rominiyi, Ola Al-Tamimi, Yahia Collis, Spencer J. |
author_sort | Rominiyi, Ola |
collection | PubMed |
description | In this perspective, we congratulate the international efforts to highlight critical challenges in brain tumor research through a recent Consensus Statement. We also illustrate the importance of developing more accurate and clinically relevant early translational in vitro brain tumor models—a perspective given limited emphasis in the Consensus Statement, despite in vitro models being widely used to prioritize candidate therapeutic strategies prior to in vivo studies and subsequent clinical trials. We argue that successful translation of effective novel treatments into the clinic will require investment into the development of more predictive early pre-clinical models. It is in the interest of researchers, clinicians, and ultimately, patients that the most promising therapeutic candidates are identified and translated toward use in the clinic. Highlighting the value of early pre-clinical brain tumor models and debating how such models can be improved is of the utmost importance to the neuro-oncology research community and cancer research more broadly. |
format | Online Article Text |
id | pubmed-6468723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64687232019-04-24 The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? Rominiyi, Ola Al-Tamimi, Yahia Collis, Spencer J. Cancers (Basel) Perspective In this perspective, we congratulate the international efforts to highlight critical challenges in brain tumor research through a recent Consensus Statement. We also illustrate the importance of developing more accurate and clinically relevant early translational in vitro brain tumor models—a perspective given limited emphasis in the Consensus Statement, despite in vitro models being widely used to prioritize candidate therapeutic strategies prior to in vivo studies and subsequent clinical trials. We argue that successful translation of effective novel treatments into the clinic will require investment into the development of more predictive early pre-clinical models. It is in the interest of researchers, clinicians, and ultimately, patients that the most promising therapeutic candidates are identified and translated toward use in the clinic. Highlighting the value of early pre-clinical brain tumor models and debating how such models can be improved is of the utmost importance to the neuro-oncology research community and cancer research more broadly. MDPI 2019-03-25 /pmc/articles/PMC6468723/ /pubmed/30934632 http://dx.doi.org/10.3390/cancers11030426 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Rominiyi, Ola Al-Tamimi, Yahia Collis, Spencer J. The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? |
title | The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? |
title_full | The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? |
title_fullStr | The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? |
title_full_unstemmed | The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? |
title_short | The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? |
title_sort | ‘ins and outs’ of early preclinical models for brain tumor research: are they valuable and have we been doing it wrong? |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468723/ https://www.ncbi.nlm.nih.gov/pubmed/30934632 http://dx.doi.org/10.3390/cancers11030426 |
work_keys_str_mv | AT rominiyiola theinsandoutsofearlypreclinicalmodelsforbraintumorresearcharetheyvaluableandhavewebeendoingitwrong AT altamimiyahia theinsandoutsofearlypreclinicalmodelsforbraintumorresearcharetheyvaluableandhavewebeendoingitwrong AT collisspencerj theinsandoutsofearlypreclinicalmodelsforbraintumorresearcharetheyvaluableandhavewebeendoingitwrong AT rominiyiola insandoutsofearlypreclinicalmodelsforbraintumorresearcharetheyvaluableandhavewebeendoingitwrong AT altamimiyahia insandoutsofearlypreclinicalmodelsforbraintumorresearcharetheyvaluableandhavewebeendoingitwrong AT collisspencerj insandoutsofearlypreclinicalmodelsforbraintumorresearcharetheyvaluableandhavewebeendoingitwrong |